Pay in 4 interest-free payments of $7.02 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
The research, involving 170,000+ patients across 43 U.S
Almost 37% of those on semaglutide showed less liver scarring, compared to nearly 23% in the placebo group
To give you a quick recap: Semaglutide acts like GLP-1 Tirzepatide acts like GLP-1 and GIP Retatrutide acts like GLP-1, GIP and GCG That means that they may all bring on different weight loss results (which is what the research shows)
Further studies are needed to confirm or reject this hypothesis and to better understand the relationship between semaglutide and NAION
Nevertheless, GLP-1 agonists may be part of the future therapeutic options for this disease
US$ 22.12
US$ 26.18
US$ 29.35
